• December 29, 2010
    MADISON, N.J.--Pfizer Animal Health today announced an agreement to acquire Synbiotics Corporation (Pinksheets SYNB.PK), a privately held, Kansas City-based leader in the development, manufacture and marketing of immunodiagnostic tests for companion and food production animals. Veterinary immunodiagnostics, a methodology using antigen-antibody reaction to detect viruses or bacteria in animals, is a sector growing an estimated 8%more...
  • November 10, 2010
    DURHAM, N.C.--A new animal health research collaboration aimed at finding better ways of preventing and managing disease and advancing sustainable animal agriculture and welfare was announced today by Pfizer Animal Health and the Easter Bush Research Consortium (EBRC) – one of the largest veterinary research and education consortiums in Europe. The collaboration sets a new standard in animal health research and innovation and is backedmore...
  • July 7, 2010
    NEW YORK--As the global dairy industry continues to raise the bar on milk quality, Pfizer Animal Health recognizes a need for easy access to resources to help producers improve their milk quality decision-making. As a result, the company has launched a new online resource —www.milkqualityfocus.com— offering technical and actionable information on mastitis management and milk quality. "We understand the challenges dairy producers facemore...
  • June 11, 2010
    NEW YORK--Pfizer Animal Health today furthered its commitment to safe food from cattle by announcing a global licensing agreement with Epitopix that will expand access to its conditionally licensed Escherichia Coli Bacterial Extract vaccine* to U.S. cattle producers this fall. “Pfizer Animal Health supports cattle producers’ continuing strides against harmful bacteria, often the most frequent causes of food borne illnesses inmore...
  • May 25, 2010
    NEW YORK--Pfizer Animal Health today announced its acquisition of Microtek International, Inc., a recognized innovator in aquaculture vaccines, R&D and healthcare diagnostic services. The acquisition further expands Pfizer’s commitment to a safe food supply from healthy beef and dairy cattle, swine, poultry and, now, fish. Total global fish production – largely for human consumption – now exceeds that of pork, poultry, beef or dairy. Farmedmore...
  • March 23, 2010
    NEW YORK--Because pet owners may be even more confused this spring about how to safely use topical flea-and-tick control treatments, Pfizer Animal Health is encouraging pet owners to consult with their veterinarian, instead of attempting to manage flea-and-tick control on their own. This month, the U.S. Environmental Protection Agency (EPA) announced new actions to increase the safety of dozens of spot-on pesticide products thatmore...
  • February 18, 2010
    NEW YORK--In 2009, Pfizer Animal Health contributed more than $1.3 million to support FFA programs and help fund the American Association of Bovine Practitioners (AABP) Foundation/Pfizer Veterinary Student Scholarships through a unique partnership with veterinarians, animal health suppliers and dealers. Today, Pfizer announces the same program is available for 2010 through March 31. During this time, eligible accounts completing anmore...
  • February 15, 2010
    LAS VEGAS--Pfizer Animal Health today announced that the U.S. Food and Drug Administration (FDA) has approved EXCEDE® Sterile Suspension as the first safe and effective, long-acting antibiotic formulation licensed for horses. EXCEDE Sterile Suspension is the newest addition to Pfizer Animal Health’s extensive portfolio of equine products backed by scientific research and innovation in the field of equine medicine. EXCEDE Sterilemore...
  • February 8, 2010
    TOKYO--Pfizer Animal Health today announced it will begin to expand Japanese veterinary experience with IMPROVAC, Pfizer’s successful pork production technology embraced by pig farmers in other countries for more than 10 years. The Japanese Ministry of Agriculture Forestry and Fishery (JMAFF) has approved IMPROVAC as safe and effective for use by veterinarians in pigs throughout Japan. "In the months ahead, the experience gained withmore...
  • February 1, 2010
    SYDNEY--Pfizer Animal Health today announced the completion of the previously-announced divestiture of certain Fort Dodge veterinary assets in Australia to Virbac (Australia) Pty Limited. The financial terms of the transaction were not disclosed. Pfizer divested the assets in compliance with requirements imposed by the ACCC in connection with Pfizer’s acquisition of Wyeth, including the Fort Dodge business, by Pfizer in October 2009more...